← Back to Patent Explorer
US4757016A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for stabilizing the activity of peroxidase in solution

Assignee: Roche Diagnostics GmbH
•
Filing: 1986-03-04
•
Granted: 1988-07-12
•
Expires: 2006-03-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides a process for stabilizing the activity of peroxidase in solution by the addition of a specific activity stabilizer, wherein, to the enzyme present in solid or dissolved form, when the peroxidase is used as a conjugate with an immunologically effective substance, there is added, as activity stabilizer, aminopyrine in an amount of from 0.0005 to 2% by weight, referred to the solution.

Inventors

  • 👤 Dagmar Klenner
  • 👤 Gerd Kleinhammer
  • 👤 Rolf Deeg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 15:54
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/96; C12Q; C12Q1/00; C12Q1/26; C12Q1/28; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/535

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 60 words
A process for stabilizing the activity of peroxidase enzyme in solution wherein the peroxidase is used as a conjugate with an immunologically effective substance by the addition of a specific stabilizer comprising adding to the enzyme in solid or dissolved form as the activity stabilizer, aminopyrine in an amount of from 0.0005 to 2% by weight, referred to the solution.
Claim 2
Dependent Claim 60 words
A process for stabilizing the activity of peroxidase enzyme in solution wherein the peroxidase is used as a conjugate with an immunologically effective substance by the addition of a specific stabilizer comprising adding to the enzyme in solid or dissolved form as the activity stabilizer, aminopyrine in an amount of from 0.0005 to 2% by weight, referred to the solution.
Claim 3
Dependent Claim 15 words
The process of claim 1, wherein 0.005 to 1% by weight of aminopyrine are added.
Claim 4
Dependent Claim 16 words
The process of claim 1 further comprising, after the aminopyrine is added, lyophilizing the enzyme solution.
Claim 5
Dependent Claim 31 words
The process of claim 1, wherein the enzyme is in the form of a lyophilizate which has been reconstituted in aqueous solvent and the aminopyrine is added to the reconstituted lyophilisate.
Claim 6
Dependent Claim 21 words
The process of claim 1, wherein the immunologically-effective substance is an antibody or a fragment thereof, an antigen or a hapten.
Claim 7
Dependent Claim 22 words
The process of claim 5, wherein the immunologically-effective substance is digoxin, digoxigenin, or thyroxin or an antibody against TSH, ferritin or AFP.
Claim 8
Dependent Claim 17 words
The process of claim 5, wherein the immunologically-effective substance is an antibody against AFP, ferritin or TSH.
Claim 9
Dependent Claim 11 words
The process of claim 1 further comprising adding a preserving agent.
Claim 10
Dependent Claim 29 words
A composition comprising a stabilized peroxidase enzyme preparation wherein the peroxidase is conjugated with an immunologically effective substance peroxidase together with 0.005 to 2% by weight of amino pyrine.
Claim 11
Dependent Claim 29 words
A composition comprising a stabilized peroxidase enzyme preparation wherein the peroxidase is conjugated with an immunologically effective substance peroxidase together with 0.005 to 2% by weight of amino pyrine.
Claim 12
Dependent Claim 25 words
The process of claim 5 wherein the immunologically-effective substance is TBG, cortisol, vitamin B12, or an antibody against hCG, LH, FSH, prolactin, CEA or insulin.
Claim 13
Dependent Claim 18 words
The stabilized peroxidase enzyme preparation of claim 9 wherein 0.005 to 1% by weight of aminopyrine is used.
Claim 14
Dependent Claim 23 words
The stabilized peroxidase enzyme preparation of claim 11 wherein the immunologically-effective substance is an antibody or fragment thereof, an antigen or a hapten.

References Cited (Backward Citations)

US4331761A Cited
EP0024578A1 Cited
US4378429A Cited
US4252896A Cited
US4350762A Cited
EP0070992A1 Cited
US4504579A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-07-12 1992-01-11 1992-07-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-07-12 1996-01-11 1996-07-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-07-12 2000-01-11 2000-07-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag